- Home
- SUPN vs SKWD Comparison
SUPN vs SKWD Comparison
Compare SUPN & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- SKWD
- Stock Information
- Founded
- SUPN 2005
- SKWD 2007
- Country
- SUPN United States
- SKWD United States
- Employees
- SUPN N/A
- SKWD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- SKWD Property-Casualty Insurers
- Sector
- SUPN Health Care
- SKWD Finance
- Exchange
- SUPN Nasdaq
- SKWD Nasdaq
- Market Cap
- SUPN 1.9B
- SKWD 2.4B
- IPO Year
- SUPN 2012
- SKWD 2023
- Fundamental
- Price
- SUPN $31.98
- SKWD $55.31
- Analyst Decision
- SUPN Hold
- SKWD Buy
- Analyst Count
- SUPN 2
- SKWD 12
- Target Price
- SUPN $36.00
- SKWD $63.88
- AVG Volume (30 Days)
- SUPN 693.3K
- SKWD 430.3K
- Earning Date
- SUPN 08-05-2025
- SKWD 08-04-2025
- Dividend Yield
- SUPN N/A
- SKWD N/A
- EPS Growth
- SUPN N/A
- SKWD 9.29
- EPS
- SUPN 1.11
- SKWD 2.98
- Revenue
- SUPN $667,997,000.00
- SKWD $1,213,759,000.00
- Revenue This Year
- SUPN N/A
- SKWD $18.33
- Revenue Next Year
- SUPN $12.02
- SKWD $11.61
- P/E Ratio
- SUPN $28.89
- SKWD $18.78
- Revenue Growth
- SUPN 11.82
- SKWD 26.30
- 52 Week Low
- SUPN $25.55
- SKWD $34.10
- 52 Week High
- SUPN $40.28
- SKWD $65.05
- Technical
- Relative Strength Index (RSI)
- SUPN 48.95
- SKWD 37.51
- Support Level
- SUPN $30.93
- SKWD $53.27
- Resistance Level
- SUPN $32.78
- SKWD $58.18
- Average True Range (ATR)
- SUPN 1.00
- SKWD 1.67
- MACD
- SUPN -0.03
- SKWD -0.43
- Stochastic Oscillator
- SUPN 46.56
- SKWD 26.64
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.